Clinical Trials Logo

Oral Manifestations clinical trials

View clinical trials related to Oral Manifestations.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05938166 Recruiting - Swallowing Disorder Clinical Trials

The Effects of Using Augmented Reality (AR) Simulation System to Train Foreign Care Workers.

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the effect of augmented reality (AR) simulation training intervention of foreign care workers on the oral function of older people. This randomized controlled trial included experimental group: AR group (EG) and control group(CG), respectively. The EG will receive augmented reality (AR) simulation training intervention with traditional classroom oral health education. The CG only receive traditional classroom oral health education.

NCT ID: NCT04706156 Recruiting - Covid19 Clinical Trials

Oral Side Effects of COVID-19 Vaccine

Start date: January 27, 2021
Phase:
Study type: Observational

This study is a multicenter cross-sectional survey-based study conducted in four European countries (Czech Republic, Germany, Slovak Republic, and Turkey). An online questionnaire will be utilized to collect data from volunteer subjects following the STROBE reporting guidelines of cross-sectional studies.

NCT ID: NCT04391881 Recruiting - Clinical trials for Oral Health and COVID 19

Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population

Start date: May 30, 2020
Phase:
Study type: Observational

The oral manifestation of COVID 19 that could help in the diagnosis of patient

NCT ID: NCT02662465 Recruiting - Mucositis Clinical Trials

Oral Manifestations in Children With Cancer

Start date: December 2015
Phase: N/A
Study type: Interventional

Before the start of the selected chemotherapy patients will be treated preventively for oral mucositis. A group will carry out the mouthwash with chlorhexidine 0.12% twice a day for five days and another will be held to damage preventive therapy (wavelength of 660nm, power 100mW and lluencia of 4 J / cm² per point, with distance of 2cm between points located on the right buccal mucosa, left buccal mucosa, hard palate, upper lip and lower lip). Patients who develop oral mucositis even after the prevention, will be divided into three groups for laser sessions with the purpose of treatment of oral mucositis. The group assignment obeyed severity of oral mucositis. Group 1 will include patients with oral mucositis grade 1. Sera used wavelength of 660nm, power 100mW and lluencia of 4 J / cm². Group 2 included patients with oral mucositis grade 2. Sera used with a wavelength of 660nm, power 100mW and lluencia of 8 J / cm². Group 3 included patients with oral mucositis grade 3 Sera used laser diode AsGaAl operating in continuous mode, with a wavelength of 790 nm, power of 100mW and fluency of 8 J / cm².